基本情報
- CAS
98629-43-7- 標準SMILES
NCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCN=C(N)N- InChIKey
IDINUJSAMVOPCM-UHFFFAOYSA-N- 分子式
- C17H37N7O3
- 平均分子量
- 387.5 g/mol
- 単同位体質量
- 387.29578807
概要
Gusperimus is a N-acyl-amino acid.
名称と識別子
- 優先名称
- Gusperimus
- IUPAC
- N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide
- 英語名
- N-[4-(3-aminopropylamino)butylcarbamoyl-hydroxy-methyl]-7-(diaminomethylideneamino)heptanamide
- 分子式
- C17H37N7O3
- 分子量
- 387.52
名称と別名
Gusperimus98629-43-715-deoxyspergualinUJ0ZJ76DO9Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-DTXSID60861078gusperimusumHeptanamide, 7-[(aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amino]-1-hydroxy-2-oxoethyl]-RefChem:144798DTXCID00197287L04AA19N-(((4-((3-aminopropyl)amino)butyl)carbamoyl)(hydroxy)methyl)-7-carbamimidamidoheptanamide
名称をさらに表示
Reaxys ID: 25858884Deoxyspergualin Impurity 1N-[4-(3-aminopropylamino)butylcarbamoyl-hydroxy-methyl]-7-(diaminomethylideneamino)heptanamide
Gusperimus [INN]104317-84-2N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamideGusperimus (INN)N-(2-((4-((3-Aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-7-guanidinoheptanamideBMS 181173(+/-)-DeoxyspergualinNCGC00183869-01
データベース識別子
- CAS
物性
構造計算による物性
- XLogP
- -2
- 極性表面積
- 181 Ų
- 水素結合供与体数
- 7
- 水素結合受容体数
- 6
- 回転可能結合数
- 17
- 重原子数
- 27
- 形式電荷
- 0
- 複雑度
- 429
物理化学的性質
- 比重(密度)
- 1.26 · 1.26±0.1 g/cm3(Predicted)
- 酸解離定数(Pka)
- 11.59 · 11.59±0.20(Predicted)
化学と産業
薬理情報
ATC Code
L - Antineoplastic and immunomodulating agents
QL - Antineoplastic and immunomodulating agents
MeSH Pharmacological Classification
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
Substances which lower blood glucose levels.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military.
サプライヤー6 社
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
浙江珲达生物科技有限公司0571-89903022 18679456698 · [email protected]
BOC Sciences+1-631-485-4226 · [email protected]
TargetMol中国（陶术生物）15002134094 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…